 StandardNet | Novartis cancer drug gets Phl FDA approval Philippine Star MANILA, Philippines - The Novartis anti-cancer drug everolimus, in combination with aromatase inhibitor, is now approved in the Philippines for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer, ... Europe Approves Everolimus in Advanced Breast Cancer EU approves new breast cancer drug |
